Guidance on Prevention of Viral Hepatitis B and C Among People Who Inject Drugs
- PMID: 23805439
- Bookshelf ID: NBK144127
Guidance on Prevention of Viral Hepatitis B and C Among People Who Inject Drugs
Excerpt
The guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. The following recommendations are based on systematic reviews of scientific evidence, community values and preferences and implementation issues. Recommendation 1: It is suggested to offer people who inject drugs the rapid hepatitis B vaccination regimen. Recommendation 2: It is suggested to offer people who inject drugs incentives to increase uptake and completion of the hepatitis B vaccine schedule. Recommendation 3: It is suggested that needle and syringe programs also provide low dead-space syringes for distribution to people who inject drugs. Recommendation 4: Psychosocial interventions are not suggested for people who inject drugs to reduce the incidence of viral hepatitis. Recommendation 5: It is suggested to offer peer interventions to people who inject drugs to reduce the incidence of viral hepatitis.
Copyright © 2012, World Health Organization.
Sections
- ACKNOWLEDGEMENTS
- FUNDING AND DECLARATIONS OF INTEREST
- ABBREVIATIONS AND ACRONYMS
- EXECUTIVE SUMMARY
- 1. INTRODUCTION
- 2. SCOPE AND OBJECTIVES
- 3. BACKGROUND
- 4. METHODOLOGY
- 5. GUIDING PRINCIPLES
- 6. RECOMMENDATIONS
- 7. EXISTING RECOMMENDATIONS
- 8. ADAPTING THESE GUIDELINES
- 9. OPERATIONAL AND IMPLEMENTATION ISSUES
- 10. NEXT STEPS
- REFERENCES
- ANNEXES
Publication types
LinkOut - more resources
Full Text Sources